相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of SGLT2 inhibitors and GLP1-receptor agonists on cardiovascular and limb events in peripheral artery disease: A review
Nedaa Skeik et al.
VASCULAR MEDICINE (2023)
Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial
Kausik K. Ray et al.
LANCET DIABETES & ENDOCRINOLOGY (2023)
Pleiotropic effects of GLP-1 receptor agonists on peripheral artery disease: Is there any hope?
Paola Caruso et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)
Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis
Jose Seijas-Amigo et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2023)
Guideline-Directed Medical Therapy and Long-Term Mortality and Amputation Outcomes in Patients Undergoing Peripheral Vascular Interventions
Kim G. Smolderen et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2023)
Associations of lower-limb atherosclerosis and arteriosclerosis with cardiovascular risk factors and disease in older adults: The Atherosclerosis Risk in Communities (ARIC) study
Keeron Stone et al.
ATHEROSCLEROSIS (2022)
European Society of Cardiology: cardiovascular disease statistics 2021
Adam Timmis et al.
EUROPEAN HEART JOURNAL (2022)
Supervised Exercise Therapy is Effective for Patients With Intermittent Claudication Regardless of Psychological Constructs
Sandra C. P. Jansen et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2022)
Effect of SGLT2 inhibitors versus DPP4 inhibitors or GLP-1 agonists on diabetic foot-related extremity amputation in patients with T2DM: A meta-analysis
Yaping Du et al.
PRIMARY CARE DIABETES (2022)
Smoking Cessation Improves Outcomes in Patients With Peripheral Artery Disease
Mark A. Creager et al.
JAMA CARDIOLOGY (2022)
Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies
Irene Caruso et al.
METABOLITES (2022)
Atherosclerosis: Recent developments
Johan L. M. Bjoerkegren et al.
CELL (2022)
Lower limb amputations: protection with GLP-1 receptor agonists rather than increased risk with SGLT2 inhibitors?
Andre J. Scheen
DIABETES & METABOLISM (2022)
Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community
Ramachandran S. Vasan et al.
HYPERTENSION (2022)
Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention
Hussein Bashar et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2022)
Role of Lipid-Lowering Therapy in Peripheral Artery Disease
Agastya D. Belur et al.
JOURNAL OF CLINICAL MEDICINE (2022)
2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations
Michel Zeitouni et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
Smoking and the Pathophysiology of Peripheral Artery Disease
Weiming Wang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Impact of pre-existent vascular and poly-vascular disease on acute myocardial infarction management and outcomes: An analysis of 2 million patients from the National Inpatient Sample
Ofer Kobo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Assessment and management of peripheral arterial disease: what every cardiologist should know
Bao Tran
HEART (2021)
Prevalence of asymptomatic carotid artery stenosis in Chinese patients with lower extremity peripheral arterial disease: a cross-sectional study on 653 patients
Zhui Li et al.
BMJ OPEN (2021)
Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors
Donna Shu-Han Lin et al.
DIABETOLOGIA (2021)
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy
Victor Aboyans et al.
EUROPEAN HEART JOURNAL (2021)
Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review
Udaya Ralapanawa et al.
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2021)
Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review
Giancarlo Agnelli et al.
ATHEROSCLEROSIS (2020)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Juhani Knuuti et al.
EUROPEAN HEART JOURNAL (2020)
Arterial stiffness and 5-year mortality in patients with peripheral arterial disease
Giovanni Scandale et al.
JOURNAL OF HUMAN HYPERTENSION (2020)
Adherence to Guideline-Recommended Therapy-Including Supervised Exercise Therapy Referral-Across Peripheral Artery Disease Specialty Clinics: Insights From the International PORTRAIT Registry
John T. Saxon et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis
Daniele Pastori et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Evaluating Multisite Atherosclerosis and its Progression Ready for Prime Time?
Nathan D. Wong
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Improved survival with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic limb-threatening ischemia
Sikandar Z. Khan et al.
JOURNAL OF VASCULAR SURGERY (2020)
Rivaroxaban in Peripheral Artery Disease after Revascularization
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58
Marc P. Bonaca et al.
CIRCULATION (2020)
Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease
J. Aaron Barnes et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial
J. Wouter Jukema et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Physical Activity, All-Cause and Cardiovascular Mortality, and Cardiovascular Disease
William E. Kraus et al.
MEDICINE & SCIENCE IN SPORTS & EXERCISE (2019)
Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis
Peige Song et al.
LANCET GLOBAL HEALTH (2019)
Successful Smoking Cessation Associated with Walking Behavior in Patients with Claudication
Sherene E. Sharath et al.
ANNALS OF VASCULAR SURGERY (2019)
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Victor Aboyans et al.
EUROPEAN HEART JOURNAL (2018)
Risk of peripheral artery disease according to a healthy lifestyle score: The PREDIMED study
Nieves Lopez-Laguna et al.
ATHEROSCLEROSIS (2018)
Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome
Fredrik Sartipy et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2018)
Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA Study
Jean-Philippe Collet et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Prevalence of previously unrecognized peripheral arterial disease in patients undergoing coronary angiography
Akram Saleh et al.
MEDICINE (2018)
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Marc P. Bonaca et al.
CIRCULATION (2018)
The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial
Ketan Dhatariya et al.
DIABETES CARE (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial
Marc P. Bonaca et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Canagliflozin and Cardiovascular disease- results of the CANVAS trial
Syed Raza Shah et al.
JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES (2018)
Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China
Fiona Bragg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
William R. Hiatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Epidemiology of coronary heart disease and acute coronary syndrome
Fabian Sanchis-Gomar et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
The ARTICO study: identification of patients at high risk of vascular recurrence after a first non-cardioembolic stroke
Joaquin Serena et al.
BMC NEUROLOGY (2015)
Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort The PESA (Progression of Early Subclinical Atherosclerosis) Study
Leticia Fernandez-Friera et al.
CIRCULATION (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults
Connor A. Emdin et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults
Connor A. Emdin et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Usefulness of the Ankle-Brachial Index to Predict High Coronary SYNTAX Scores, Myocardium at Risk, and Incomplete Coronary Revascularization
Meghan Sebastianski et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Adherence to Guideline-Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
Ehrin J. Armstrong et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Multisite artery disease: a common and challenging clinical condition calling for specific management
Paola Di Noi et al.
FUTURE CARDIOLOGY (2014)
Peripheral Arterial Disease Is Prevalent But Underdiagnosed and Undertreated in the Primary Care Setting in Central Greece
Christos Argyriou et al.
ANGIOLOGY (2013)
Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication
Yousef Shahin et al.
ATHEROSCLEROSIS (2013)
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II
Vasim Farooq et al.
LANCET (2013)
Measurement and Interpretation of the Ankle-Brachial Index A Scientific Statement From the American Heart Association
Victor Aboyans et al.
CIRCULATION (2012)
Two-year Vascular Hospitalisation Rates and Associated Costs in Patients at Risk of Atherothrombosis in France and Germany: Highest Burden for Peripheral Arterial Disease
K. G. Smolderen et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2012)
Management of peripheral arterial interventions with mono or dual antiplatelet therapy-the MIRROR study: a randomised and double-blinded clinical trial
Gunnar Tepe et al.
EUROPEAN RADIOLOGY (2012)
One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry
Kim G. Smolderen et al.
CANADIAN JOURNAL OF CARDIOLOGY (2010)
High Prevalence of Peripheral Arterial Disease in Patients with Acute Ischaemic Stroke
Raffi Topakian et al.
CEREBROVASCULAR DISEASES (2010)
Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Index A Randomized Controlled Trial
F. Gerald R. Fowkes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial
Jill J. F. Belch et al.
JOURNAL OF VASCULAR SURGERY (2010)
Prevalence of Asymptomatic Carotid Artery Stenosis in the General Population An Individual Participant Data Meta-Analysis
Marjolein de Weerd et al.
STROKE (2010)
Sex differences in the prevalence of peripheral artery disease in patients undergoing coronary catheterization
Amir H. Sadrzadeh Rafie et al.
VASCULAR MEDICINE (2010)
Dissociation of Aortic Pulse Wave Velocity With Risk Factors for Cardiovascular Disease Other Than Hypertension A Systematic Review
Marina Cecelja et al.
HYPERTENSION (2009)
Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
Jill Belch et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
JOURNAL OF VASCULAR SURGERY (2007)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease
J Ostergren et al.
EUROPEAN HEART JOURNAL (2004)
Premature cardiovascular disease is common in relatives of patients with premature peripheral atherosclerosis
RJ Valentine et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
分享论文
